Results for the year ended 31 March 2026

Summary by AI BETAClose X

Optima Health Plc reported a strong financial performance for the year ended 31 March 2026, with revenue increasing by 14.8% to £120.6 million and adjusted EBITDA reaching £20.1 million, exceeding market expectations by 10%. The company completed a significant £100 million acquisition of PAM Healthcare Limited, enhancing its scale and capabilities, and has already delivered £2.1 million in annualised cost synergies. Integration of PAM is progressing as planned, and the company is on track to meet its medium-term targets of £200 million in annual revenue and £40 million in adjusted EBITDA. The company also recognized £4.7 million in other operating income from a settled procurement matter and is progressing with the mobilization of the UK Armed Forces Recruitment Service contract, valued at up to £210 million over seven years. Net debt stood at £94.4 million at year-end, reflecting the PAM acquisition financing.

Disclaimer*

UK 100

Latest directors dealings